Back
Citius Pharmaceuticals, Inc. Stock Predictions
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
42
CTXR
Citius Pharmaceuticals, Inc.
Last Price:
$1.23
Seasonality Move:
23.69%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiCitius Pharmaceuticals, Inc. Stock Forecast
-
Is Citius Pharmaceuticals, Inc. Stock Undervalued?The current Citius Pharmaceuticals, Inc. [CTXR] share price is $1.25. The Score for CTXR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
CTXR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Citius Pharmaceuticals, Inc. Stock Go Up Next Year?
Data Unavailable
Citius Pharmaceuticals, Inc. Stock Rating
Data Unavailable
Citius Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
citiuspharma.com
52-Week Data
52-Week High:
5.95
52-Week Low:
0.65
Prediction Charts
Market Cap:
23.1M
Price in USD:
1.25
Volume:
469.3K
Beta:
1.23
Technical Analysis
SMA50:
1.33
SMA100:
1.32
SMA200:
1.26
52-Wk Change:
-65.66%
Stock Predictions
-
Is Citius Pharmaceuticals, Inc. stock public?Yes, Citius Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Citius Pharmaceuticals, Inc. stock quote today?The Citius Pharmaceuticals, Inc. stock price is 1.25 USD today.
-
How to buy Citius Pharmaceuticals, Inc. stock online?You can buy Citius Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 1.01 | 0.98 | 1.03 | 0.94 |
| Nov-17 | 0.98 | 0.94 | 0.98 | 0.92 |
| Nov-18 | 0.93 | 1.07 | 1.10 | 0.93 |
| Nov-19 | 1.06 | 1.00 | 1.08 | 0.98 |
| Nov-20 | 1.03 | 0.99 | 1.07 | 0.97 |
| Nov-21 | 1.05 | 1.14 | 1.18 | 0.99 |
| Nov-24 | 1.14 | 1.14 | 1.17 | 1.06 |
| Nov-25 | 1.18 | 1.22 | 1.24 | 1.13 |
| Nov-26 | 1.28 | 1.40 | 1.54 | 1.28 |
| Nov-28 | 1.47 | 1.44 | 1.48 | 1.36 |
| Dec-1 | 1.42 | 1.35 | 1.42 | 1.28 |
| Dec-2 | 1.41 | 1.26 | 1.41 | 1.25 |
| Dec-3 | 1.27 | 1.15 | 1.29 | 1.14 |
| Dec-4 | 1.15 | 1.25 | 1.27 | 1.12 |
Citius Pharmaceuticals, Inc. Earnings
Data Unavailable
Citius Pharmaceuticals, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.55 per share, and an increase next year of $3.98 per share.
* Citius Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.